327 related articles for article (PubMed ID: 11821466)
1. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial.
Marijnen CA; Kapiteijn E; van de Velde CJ; Martijn H; Steup WH; Wiggers T; Kranenbarg EK; Leer JW;
J Clin Oncol; 2002 Feb; 20(3):817-25. PubMed ID: 11821466
[TBL] [Abstract][Full Text] [Related]
2. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
[TBL] [Abstract][Full Text] [Related]
3. No downstaging after short-term preoperative radiotherapy in rectal cancer patients.
Marijnen CA; Nagtegaal ID; Klein Kranenbarg E; Hermans J; van de Velde CJ; Leer JW; van Krieken JH;
J Clin Oncol; 2001 Apr; 19(7):1976-84. PubMed ID: 11283130
[TBL] [Abstract][Full Text] [Related]
4. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.
Siegel R; Burock S; Wernecke KD; Kretzschmar A; Dietel M; Loy V; Koswig S; Budach V; Schlag PM
BMC Cancer; 2009 Feb; 9():50. PubMed ID: 19200365
[TBL] [Abstract][Full Text] [Related]
5. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
van Gijn W; Marijnen CA; Nagtegaal ID; Kranenbarg EM; Putter H; Wiggers T; Rutten HJ; Påhlman L; Glimelius B; van de Velde CJ;
Lancet Oncol; 2011 Jun; 12(6):575-82. PubMed ID: 21596621
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial.
Wiltink LM; Chen TY; Nout RA; Kranenbarg EM; Fiocco M; Laurberg S; van de Velde CJ; Marijnen CA
Eur J Cancer; 2014 Sep; 50(14):2390-8. PubMed ID: 25060825
[TBL] [Abstract][Full Text] [Related]
7. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.
Kapiteijn E; Kranenbarg EK; Steup WH; Taat CW; Rutten HJ; Wiggers T; van Krieken JH; Hermans J; Leer JW; van de Velde CJ
Eur J Surg; 1999 May; 165(5):410-20. PubMed ID: 10391155
[TBL] [Abstract][Full Text] [Related]
8. Does preoperative radiotherapy with postoperative chemotherapy increase acute side-effects and postoperative complications of total mesorectal excision? Report of the randomized Finnish rectal cancer trial.
Salmenkylä S; Kouri M; Österlund P; Pukkala E; Luukkonen P; Hyöty M; Pääkkönen M; Mäkelä J; Mustonen H; Järvinen HJ;
Scand J Surg; 2012; 101(4):275-82. PubMed ID: 23238504
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
11. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
12. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial.
Chen TY; Wiltink LM; Nout RA; Meershoek-Klein Kranenbarg E; Laurberg S; Marijnen CA; van de Velde CJ
Clin Colorectal Cancer; 2015 Jun; 14(2):106-14. PubMed ID: 25677122
[TBL] [Abstract][Full Text] [Related]
13. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer.
Yeh CH; Chen MF; Lai CH; Huang WS; Lee SP; Chen WC
Int J Clin Oncol; 2012 Oct; 17(5):482-90. PubMed ID: 21938495
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
16. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
17. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy.
van den Brink M; Stiggelbout AM; van den Hout WB; Kievit J; Klein Kranenbarg E; Marijnen CA; Nagtegaal ID; Rutten HJ; Wiggers T; van de Velde CJ
J Clin Oncol; 2004 Oct; 22(19):3958-64. PubMed ID: 15459218
[TBL] [Abstract][Full Text] [Related]
18. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
[TBL] [Abstract][Full Text] [Related]
19. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial.
Wiltink LM; Marijnen CA; Meershoek-Klein Kranenbarg E; van de Velde CJ; Nout RA
Acta Oncol; 2016; 55(4):502-8. PubMed ID: 26406287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
